Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PLXP

PLx Pharma (PLXP) Stock Price, News & Analysis

PLx Pharma logo

About PLx Pharma Stock (NASDAQ:PLXP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3,000 shs
Average Volume
12.96 million shs
Market Capitalization
$603,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. It offers PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Sparta, NJ.

Receive PLXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PLx Pharma and its competitors with MarketBeat's FREE daily newsletter.

PLXP Stock News Headlines

While others chase AI stocks, smart traders do this
Since the pandemic, the average mortgage payment has jumped from $1,427 to $2,047. That's an extra $600 every single month just vanishing from people's pockets. Meanwhile, credit card debt is hitting record highs, and savings accounts are at their lowest since 2008. Most folks are left with two options… Get a second job... or work overtime on weekends. But what if there was a third option? I just uncovered a shocking anomaly in the options market that could change everything... One that lets you target extra cash on days when most people make nothing - weekends. Think what that could mean for your monthly budget...
PLXp/USD - Pullix US Dollar
Protalix Biotherapeutics Inc (PLX)
Vertex Pharmaceuticals Inc VRTX
Vietnam National Petroleum Group (PLX)
PLx Pharma Inc (PLXPQ)
See More Headlines

PLXP Stock Analysis - Frequently Asked Questions

PLx Pharma Inc. (NASDAQ:PLXP) released its quarterly earnings results on Friday, November, 12th. The biotechnology company reported ($0.37) EPS for the quarter, topping the consensus estimate of ($0.46) by $0.09. The company's quarterly revenue was up 560.0% on a year-over-year basis.

PLx Pharma (PLXP) raised $68 million in an initial public offering (IPO) on Thursday, February 4th 2016. The company issued 3,800,000 shares at a price of $17.00-$19.00 per share. Raymond James acted as the underwriter for the IPO and Maxim Group LLC and Janney Montgomery Scott were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that PLx Pharma investors own include Sorrento Therapeutics (SRNE), Ford Motor (F), SCYNEXIS (SCYX), CymaBay Therapeutics (CBAY), Energy Transfer (ET), Meta Platforms (META) and Pfizer (PFE).

Company Calendar

Last Earnings
11/12/2021
Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PLXP
Employees
16
Year Founded
2002

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$46.13 million
Net Margins
-606.91%
Pretax Margin
-606.91%

Debt

Sales & Book Value

Annual Sales
$4.54 million
Price / Cash Flow
N/A
Book Value
$1.30 per share
Price / Book
N/A

Miscellaneous

Free Float
26,530,000
Market Cap
$603,000.00
Optionable
Not Optionable
Beta
3.79

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:PLXP) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners